Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole and Fluconazole on Selumetinib PK in Healthy Volunteers
NCT02093728Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of selumetinib in solid tumor (2 arms), sponsored by AstraZeneca. Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time Zero Extrapolated to Infinity. Started Apr 2014; status: completed.
02
Drugs
selumetinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02093728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093728.